SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 353 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $70,972,000 | -24.8% | 550,000 | -56.1% | 3.14% | -30.1% |
| Q3 2019 | $94,338,000 | +13.2% | 1,252,500 | +128.4% | 4.48% | +19.3% |
| Q2 2019 | $83,345,000 | +14.5% | 548,500 | -10.2% | 3.76% | +32.3% |
| Q1 2019 | $72,771,000 | +136.8% | 610,546 | +116.9% | 2.84% | +98.5% |
| Q4 2018 | $30,725,000 | -50.9% | 281,546 | -27.4% | 1.43% | -49.7% |
| Q3 2018 | $62,601,000 | +69.1% | 387,600 | +38.4% | 2.84% | +59.6% |
| Q2 2018 | $37,010,000 | +76.7% | 280,000 | -54.9% | 1.78% | +74.5% |
| Q2 2017 | $20,949,000 | +104.7% | 621,458 | +79.7% | 1.02% | +108.4% |
| Q1 2017 | $10,236,000 | +6.9% | 345,811 | -0.9% | 0.49% | -3.9% |
| Q4 2016 | $9,572,000 | – | 348,954 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |